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Abstract
G protein-coupled receptors (GPCRs) are critical for cardiovascular physiology. Cardiac cells express.100 nonchemosensory
GPCRs, indicating that important physiological and potential therapeutic targets remain to be discovered. Moreover, there is
a growing appreciation that members of the large, distinct taste and odorant GPCR families have specific functions in
tissues beyond the oronasal cavity, including in the brain, gastrointestinal tract and respiratory system. To date, these
chemosensory GPCRs have not been systematically studied in the heart. We performed RT-qPCR taste receptor screens in
rodent and human heart tissues that revealed discrete subsets of type 2 taste receptors (TAS2/Tas2) as well as Tas1r1 and
Tas1r3 (comprising the umami receptor) are expressed. These taste GPCRs are present in cultured cardiac myocytes and
fibroblasts, and by in situ hybridization can be visualized across the myocardium in isolated cardiac cells. Tas1r1 gene-
targeted mice (Tas1r1Cre/Rosa26tdRFP) strikingly recapitulated these data. In vivo taste receptor expression levels were
developmentally regulated in the postnatal period. Intriguingly, several Tas2rs were upregulated in cultured rat myocytes
and in mouse heart in vivo following starvation. The discovery of taste GPCRs in the heart opens an exciting new field of
cardiac research. We predict that these taste receptors may function as nutrient sensors in the heart.
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Introduction
G protein-coupled receptors (GPCRs) are seven transmem-
brane-spanning proteins that mediate cellular and physiological
responses by converting extracellular stimuli into intracellular
signals. GPCRs represent the largest receptor superfamily in the
genome, recognizing and binding an array of sensory input and
ligands, including photons, ions, odors/tastes, bioamines, lipids,
peptides and proteins [1]. Many of the ligands for these receptors,
including norepinephrine/epinephrine, endothelin and angioten-
sin have profound homeostatic and regulatory effects on the
cardiovascular system. Not surprisingly, mutations and modifica-
tions of GPCRs, G proteins and their regulatory partners are
linked to dysfunction and disease, with an estimated 40% of all
drugs on the market eliciting their activity through GPCRs [2].
Although cardiovascular therapeutics are well established clinical-
ly, they target a very small fraction of cardiac-expressed GPCRs.
Moreover, conservative estimates are that the heart expresses
upwards of 100 different nonchemosensory GPCRs, yet over 30%
of these have no known endogenous ligand, indicating that much
biology and many potential targets remain to be discovered [3,4].
A case-in-point is the chemosensory (odorant and taste)
receptors, which account for over half of the GPCR repertoire.
Previously considered exclusive mediators of olfaction and taste,
these large GPCR families have been generally neglected as drug
targets, with the exception of the fragrance and food industries [1].
However, it is becoming evident that chemosensory receptors are
expressed in diverse tissues, where they perform additional
functions and could represent important therapeutic targets. For
instance, in the mouth, the taste receptor type 1 (TAS1 in humans;
Tas1 in rodents) family sense the nutrient content of food and
mediate sweet (TAS1R2-TAS1R3) and umami (TAS1R1-TAS1R3)
taste. In other organ systems, such as in the brain [5] and
gastrointestinal tract [6,7,8], Tas1 receptors have also been
implicated in nutrient sensing and regulation of hormone release.
In addition, intriguing recent work suggests that Tas1 GPCRs act
as direct sensors to communicate amino acid availability to the
mammalian target of rapamycin complex 1 (mTORC1) and
regulate autophagy [9].
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The taste receptor type 2 (TAS2/Tas2) GPCRs encode a family
of ,30 highly divergent receptors that mediate bitter taste [1].
Tas2rs expressed in taste papillae in the tongue detect and respond
to a large number of structurally diverse aversive and toxic
compounds, resulting in canonical avoidance and rejection
responses [10]. Beyond the mouth, the Tas2rs are enigmatic,
having been implicated in several distinct functions in the airways
and throughout the gastrointestinal tract [11]. Specifically, Tas2rs
have been identified in ‘solitary’ chemosensory cells throughout
the respiratory epithelium, as well as in the airway smooth muscle,
where they might respond to bitter/toxic compounds to mediate
protective airway reflexes and bronchodilation, respectively
[12,13,14]. Tas2rs have also been identified in specialized
subpopulations of gastrointestinal cells, where they modulate
hormone release and impact on gastric emptying [15,16].
The expression of taste GPCRs is yet to be systematically
studied in the heart. Here, we report the expression of TAS1/Tas1
and TAS2/Tas2 GPCRs in human and rodent heart, their cellular
localization, developmental regulation and upregulation in condi-
tions of starvation. We speculate that one function of cardiac cells
expressing taste GPCRs might be as sentinels for cardiac nutrient
sensing.
Materials and Methods
Ethics Statement
Human hearts were obtained immediately following explanta-
tion from five patients with terminal heart failure undergoing heart
transplantation at The Prince Charles Hospital, Brisbane. Written
informed consent was obtained from each patient (ethics approval
number EC28114, Human Research Ethics Committee, Metro
North Hospital and Health Service, The Prince Charles Hospital).
All animal procedures were carried out with specific approval
from The University of Queensland Animal Welfare Unit (ethics
approval numbers SBMS/095/11/NHMRC/NHF and ANAT
DVB/658/07NHMRC) and follow the Australian Code of
Practice for the Care and Use of Animals for Scientific Purposes.
Experimental Animals and Tissue Collection
Animals were maintained on a 12 hour light/dark cycle with ad
libitum access to standard chow and water. Sprague-Dawley Rats
were killed by intraperitoneal injection of an overdose of sodium
pentobarbital. Tas1r1Cre/Rosa26tdRFP mice report the history of
activity of the Tas1r1 promoter. Briefly, Tas1r1Cre mouse line was
generated by replacing the entire Tas1r1 coding region by an
expression cassette containing the coding sequence of barley lectin,
an internal ribosomal entry site, and Cre recombinase. Hetero-
zygote gene-targeted Tas1r1Cre mice were bred with Rosa26tdRFP
mice [17], to generate Tas1r1Cre/Rosa26tdRFP mice. Tas1r1Cre/
Rosa26tdRFP mice carry one recombinant Tas1r1 and one
recombinant ROSA26 allele. The Cre recombinase is expressed
under the control of the Tas1r1 promoter; therefore a Cre-
mediated recombination leads to excision of a transcriptional stop
signal flanked by Lox-P sites and thus activates expression of
tandem dimer red fluorescent protein (tdRFP) exclusively in
Tas1r1 expressing cells. Tas2r131Cre/Rosa26tauGFP mice report the
history of activity of the Tas2r131 promoter. Briefly, Tas2r131Cre
mouse line was generated by replacing the coding region of
Tas2r131 by an expression cassette, containing the coding
sequence of barley lectin, an internal ribosomal entry site, and
Cre recombinase. Heterozygote gene-targeted Tas2r131Cre mice
were bred with Rosa26tauGFP [18], mice to generate Tas2r131Cre/
Rosa26tauGFP mouse line. These mice carry one recombinant
Tas2r131 and one recombinant ROSA26 allele. Cre recombinase
expression is controlled by Tas2r131 promoter activity. Activation
of Tas2r131 promoter leads to the expression of Cre recombinase
and therefore induces Cre-mediated recombination. This recom-
bination event leads to the excision of a transcriptional stop signal
flanked by Lox-P sites and thus activates expression of a green
fluorescent protein (tauGFP) exclusively in Tas2r131 cells. So, the
gene-targeted mouse lines (Tas1r1Cre/Rosa26tdRFP, Tas2r131Cre/
Rosa26tauGFP) express both the Cre recombinase and the taste
receptors in a heterozygote manner, as well as the fluorescent
proteins tdRFP and tauGFP, respectively.
For studies on the effects of starvation on taste GPCR
expression, C57BL/6J mice were deprived of food for 48 hours
with ad libitum access to drinking water, as described previously
[19].
Heart and tongue tissues were immediately dissected and either
rapidly frozen in liquid nitrogen for RNA extraction or fixed with
4% paraformaldehyde for cryosectioning.
Human Heart Tissue Samples
Following explantation from terminal heart failure patients
undergoing heart transplantation, human hearts were immersed in
preoxygenated (95% O225% CO2) modified Krebs’ solution
containing (mmol/L) Na+125, K+5, Ca2+2.25, Mg2+0.5, Cl2 98.5,
SO422 0.5, HCO3
2 29, HPO4
22 1, and EDTA 0.04 [20], and
samples of right atrial free wall and left ventricle were rapidly
dissected and frozen in liquid nitrogen.
Cardiomyocyte and Cardiac Fibroblast Isolation and
Culture
Ventricular cardiomyocytes and fibroblasts were isolated,
enzymatically digested and purified from one-day-old Sprague-
Dawley rat pups, as described previously [21]. Briefly, neonates
were killed by decapitation and the dissected ventricles were
enzymatically digested with pancreatin and collagenase in a cell
stirrer. Dissociated cardiac myocytes and fibroblasts were purified
through a Percoll gradient to .99% homogeneity. Cardiomyo-
cytes were plated on gelatin-coated tissue culture plates in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with sodium bicarbonate, L-glutamine, essential and non-essential
amino acids, vitamins, penicillin-streptomycin, amphotericin B,
bromodeoxyuridine (BrDu) and 10% (v/v) new born calf serum.
Myocytes were subsequently cultured in DMEM media supple-
mented with sodium bicarbonate, vitamins, essential and non-
essential amino acids, sodium pyruvate, insulin, apo-transferrin,
penicillin-streptomycin, amphotericin B, BrDu and 50 mmol/L
KCl. Cardiac fibroblasts were cultured in DMEM supplemented
with 10% (v/v) fetal bovine serum, sodium bicarbonate, penicillin-
streptomycin and amphotericin B, and were grown to confluence
in 6-well plates for RNA extraction. Nutrient deprivation
experiments were performed for 24 hours on cultured myocytes
in glucose-free DMEM media, supplemented as described above.
RNA Isolation and Reverse Transcription Quantitative PCR
(RT-qPCR)
Total RNA was extracted from human and rodent heart tissue
at various time points, as well as from isolated cardiomyocytes and
fibroblasts using TRIzol reagent (Life Technologies, Melbourne,
VIC, Australia) following homogenization with a Polytron
homogenizer, as per the manufacturer’s recommendations. RNA
was DNase-treated to remove genomic DNA contaminants and
then cDNA was synthesized from 1–6 mg of total RNA using
Superscript III (Life Technologies, Melbourne, VIC, Australia)
according to the manufacturer’s protocols. DNase treatment is
Taste GPCRs in the Heart
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particularly important for RT-qPCR experiments involving single
exon genes, such as the TAS2Rs. Reactions without reverse
transcriptase were performed in parallel to control for contami-
nation with chromosomal DNA (Figure S1A and Table S3).
RT-qPCR was used to determine mRNA expression levels of
cardiac GPCRs, taste GPCRs and taste-associated genes. 18S
ribosomal RNA and Gapdh were used as stably expressed
endogenous control genes for samples as indicated. mRNA
expression levels were measured for all human and rat genes
using Taqman probe chemistry with a StepOne Plus Real-Time
PCR System or SYBR green chemistry on an ABI7000 instrument
(Applied Biosystems, Melbourne, VIC, Australia). Primers and
probes for human and rat GPCRs and taste-associated genes, 18S
and Gapdh endogenous primers were from Applied Biosystems,
while mouse taste receptor primers were from qPrimerDepot
(accessible online: http://mouseprimerdepot.nci.nih.gov) [22]. All
primer sets and part numbers, and primer sequences are shown in
Table S1. Where possible, primers span exon boundaries,
although this is not possible for the single exon Tas2/TAS2
genes. PCR products were run on native PAGE gels to confirm
correct amplicon size (Figure S1B). For experiments using SYBR
green chemistry, melt curve analysis was performed at the
completion of each assay to determine the specificity of the PCR
reaction. Expression of the gene of interest was normalized to
Gapdh and 18S expression using the 22DDCt method [23].
Tissue Preparation and in situ Hybridization
Tissues were fixed in 4% paraformaldehyde overnight at 4uC,
rinsed in phosphate-buffered saline and incubated in 30% sucrose
solution for 6 hours. Following embedding and freezing in Tissue-
Tek OCT (Sakura Finetek, Melbourne, VIC, Australia), 10 mm
cryosections were collected on Superfrost (+) slides, and stored at
270uC. In situ hybridization was performed on rat heart using
digoxigenin (DIG) labeled-cRNA probes as described previously
[24]. See Table S2 for T3 and T7 RNA polymerase-containing
primer sequences used for in situ probe synthesis. 10 mm
cryosections were fixed, treated with proteinase K, washed in
PBS, acetylated and hybridized with gene-specific probes over-
night at 65uC. Sections were probed with anti-DIG antibody
(Roche Diagnostics, Sydney, NSW, Australia) overnight at 4uC.
Color was developed at room temperature using NBT/BCIP
(Promega, Sydney, NSW, Australia).
Data Analysis
Data expressed as mean6SEM. Statistical analyses were
performed using one-way analysis of variance (ANOVA) with a
Dunnett’s post-test or an unpaired student’s t-test, as indicated. P
values below 0.05 were considered significant and are indicated as
follows: *: P,0.05, **: P,0.01, ***P,0.001.
Results
Taste GPCRs are Expressed in the Rodent and Human
Heart
An RT-qPCR taste receptor screen in rat heart showed seven
Tas2 receptors (Tas2r108, Tas2r120, Tas2r121, Tas2r126,
Tas2r135, Tas2r137, Tas2r143), as well as two members of the
Tas1 receptor family, Tas1r1 and Tas1r3, were expressed in
neonatal whole hearts, notably at levels comparable to another
important cardiovascular GPCR, the angiotensin II type 1a
receptor (Agtr1a)(Figure 1A). The seven cardiac-expressed Tas2rs
do not display obvious sequence homology, however they cluster
into three sub-groups of proximal receptors located within the
larger group of Tas2rs on chromosome 4 in rat (or 6 in mouse),
indicating possible common upstream regulatory elements
(Figure 1B). Moreover, although the majority of rodent Tas2rs
do not have corresponding human orthologs [25], each of the
cardiac-expressed Tas2 receptors described herein does, suggesting
that the cardiac significance/function of these GPCRs may be
evolutionarily conserved (Figure S2 and Table 1).
To begin to empirically test this possibility, we obtained heart
tissue from failing human hearts and performed an RT-qPCR
screen for the taste GPCRs (Fig. 2A). Transcripts for more than
half of the TAS2R family were detected in these human left
ventricle samples, at comparatively high levels relative to the
angiotensin II type 1 receptor (AGTR1). Remarkably, TAS2R14 is
expressed at comparable levels to the b1-adrenergic receptor
(ADRB1), an abundantly expressed GPCR that is a critical
mediator of chronotropy and ionotropy in the heart. The same
receptors and relative expression patterns were observed for right
atrial tissue (Figure S3). It is also interesting to note that the human
TAS2Rs detected in heart are clustered in close genomic proximity
on chromosomes 7 and 12. As in rodents, this genomic
organization seems to correlate with the expression of particular
subsets of TAS2Rs in the heart (Figure 2B).
Localization of Taste GPCRs in the Rodent Heart
To further characterize the taste GPCRs that were identified in
our initial RT-qPCR screen, we investigated their localization in
cardiac cells. Several taste GPCRs were readily detected in
primary cultures of both isolated, purified neonatal rat cardiac
cells, and with the exception of Tas1r3, were enriched in
cardiomyocytes over fibroblasts (Figure 3A). Several genes
commonly implicated in the taste receptor signaling cascade,
specifically Gnat3, Plcb2 and Trpm5, were also expressed in
cardiomyocytes (Figure 3B).
Given the lack of selective and specific antibodies for the taste
GPCRs, in situ hybridization was used to localize taste receptor
expression in heart. In representative adult heart sections, Tas1
(Tas1r3) and Tas2 (Tas2r121) receptors showed distinct labeling in
a small proportion of cardiac cells distributed throughout the
myocardium (Figure 3C and D and inset). The probes labeled taste
receptor-expressing cells in the circumvallate papillae of the
tongue, whereas no staining was visible in sense controls. The
expression of Tas1r1 in discrete cardiac cells within the myocar-
dium was also confirmed in a Tas1r1 gene-targeted mouse
(Tas1r1Cre/Rosa26tdRFP)(Figure 3E). Importantly, another gene-
targeted mouse, Tas2r131Cre/Rosa26tauGFP exhibited strong label-
ing of taste receptor-expressing cells in the circumvallate papillae,
but no cardiac expression, consistent with our RT-qPCR data
(Figure 3F). Thus, specific taste receptor genes are expressed in
cardiac cells.
Taste GPCRs are Developmentally Regulated in the Heart
We characterized the ontogeny of taste receptor expression in
the heart, at multiple time points from neonatal (postnatal day 1)
to 19 months of age (Figure 4). Tas1r1 expression increased 2-fold
in senescent rat hearts, whereas Tas1r3 expression levels remained
constant throughout life. The Tas2rs displayed contrasting
temporal patterns of expression. Tas2r120 and Tas2r121 expres-
sion increased nearly 20-fold in adult rats relative to neonate
hearts. The remaining cardiac-expressed Tas2rs (108, 126, 135,
137 and 143) decreased in abundance with age (3–8 fold at 19
months).
Taste GPCRs in the Heart
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Figure 1. Taste GPCRs are expressed in the rodent heart. A RT-qPCR screen of taste GPCRs in neonatal rat whole heart (mean6SEM, n= 4,
normalized for Gapdh, presented as fold change over the angiotensin II type 1a receptor (Agtr1a)). B Rodent Tas2rs are predominantly clustered on
chromosome 4 (rat) and chromosome 6 (mouse). The taste GPCRs highlighted in red are detected in the heart, suggesting that these receptors may
be under transcriptional regulation of a common regulatory element.
doi:10.1371/journal.pone.0064579.g001
Taste GPCRs in the Heart
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Table 1. Homology of taste GPCRs in human and rodents.
Human Mouse Rat
Gene symbol Human vs. Mouse identity (%) Gene symbol Mouse vs. Rat identity (%) Gene symbol
Protein DNA Protein DNA
TAS1R1 74 79.6 Tas1r1 90.2 91.3 Tas1r1
TAS1R2 69.9 77.6 Tas1r2 Tas1r2
TAS1R3 73.6 75 Tas1r3 92.9 93.5 Tas1r3
TAS2R1 51.9 66.2 Tas2r119 85.3 89.7 Tas2r119
TAS2R3 64.2 77.8 Tas2r137 89.1 92.4 Tas2r137
TAS2R4 67 76.7 Tas2r108 88.2 91.1 Tas2r108
TAS2R5*
TAS2R7 68.3 79.6 Tas2r130 93.3 92.3 Tas2r130
TAS2R8*
TAS2R9*
TAS2R10 57 71.2 Tas2r114 84.5 91.2 Tas2r114
TAS2R13 59 72.3 Tas2r121 82.6 88 Tas2r121
TAS2R14 48.9 66.6 Tas2r140 78.8 86.9 Tas2r140
TAS2R16 53.8 70.5 Tas2r118 92 93 Tas2r118
TAS2R19*
TAS2R20 51.2 66.4 Tas2r120 82.7 88.8 Tas2r120
TAS2R30*
TAS2R31*
TAS2R38 65.6 76.5 Tas2r138 87.9 91.3 Tas2r38
TAS2R39 57.5 72.4 Tas2r139 85 89.6 Tas2r39
TAS2R40 66.4 78.5 Tas2r144 88.1 91.5 Tas2r40
TAS2R41 68.7 76.3 Tas2r126 90.9 92.6 Tas2r126
TAS2R42 50.5 66.4 Tas2r131 80 87.6 LOC100363053
TAS2R43*
TAS2R45*
TAS2R46*
TAS2R50*
TAS2R60 58.8 72 Tas2r135 93.1 94.1 Tas2r135
TAS2R62P 70.4 Tas2r143 87.4 91.7 Tas2r143
Tas2r102 79.3 89 Tas2r13
Tas2r103 76.6 86.4 Tas2r103
Tas2r104 86.1 91.9 Tas2r104
Tas2r105 83.9 88.7 Tas2r105
Tas2r106 84.4 91 Tas2r106
Tas2r107 85.3 89.6 Tas2r107
Tas2r109 75 85.2 Tas2r109
Tas2r110 77.3 85.6 Tas2r110
Tas2r113 79 88.3 Tas2r113
Tas2r116 73.4 85 Tas2r116
Tas2r117 77 87.8 Tas2r117
Tas2r123 80.4 87 Tas2r123
Tas2r124 81.6 88.3 Tas2r124
Tas2r125 76.1 85.6 Tas2r125
Tas2r129 78.1 87 Tas2r129
Tas2r134 82 88.7 Tas2r134
Tas2r136 75.5 85.4 Tas2r136
Human taste receptors are shown on the left, with the corresponding mouse and rat taste receptor and percentage identity at the protein and DNA level, taken from
the NCBI database (http://www.ncbi.nlm.nih.gov/homologene). Where human taste receptor homologs do exist, they are shown aligned to their rodent counterparts,
with protein and DNA identity to mouse and rat sequences. Human specific taste GPCRs are denoted with an asterisk (*).
doi:10.1371/journal.pone.0064579.t001
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Figure 2. Taste GPCRs are expressed in the human heart. A RT-qPCR screen of taste GPCRs in human left ventricle (mean6SEM, n = 5,
normalized for 18S, presented as fold change over the angiotensin II type 1 receptor (AGTR1)). The abundantly expressed b1-adrenergic receptor
(ADRB1) is shown as a comparator. B Human TASRs are localized on chromosomes 1, 5, 7 and 12, with the majority of TAS2Rs expressed in the heart
(highlighted in red) present in a cluster on chromosome 12.
doi:10.1371/journal.pone.0064579.g002
Taste GPCRs in the Heart
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Figure 3. Taste GPCRs are localized in isolated cardiac cells. A Taste receptors were detected in cultured neonatal cardiomyocytes and
fibroblasts by RT-qPCR (mean6SEM, n= 4, normalized for Gapdh and expressed relative to myocytes). B The taste receptor signal transduction genes,
including G protein (Gnat3), second messenger (PLCb2) and channel (Trpm5) are also expressed in myocytes and fibroblasts (mean6SEM, n= 4,
normalized for Gapdh and expressed relative to myocytes). C In situ hybridization using digoxigenin-labeled cRNA probes specific for Tas1r3 (left
panels) and Tas2r121 (right panels) show expression in the taste buds of the circumvallate papillae (inset shows low magnification) and D in heart
tissue (inset shows higher magnification of boxed region). Specific labeling (blue/black) is observed using antisense probes, but not sense probes. E
Tas1r1 is expressed in mouse ventricular tissue from Tas1r1Cre/Rosa26tdRFP mice, where red fluorescent cells report activity of the Tas1r1 promoter. F
In contrast, in heart sections from the Tas2r131Cre/Rosa26tauGFP reporter mouse line, there are no fluorescently-labeled myocytes (inset shows low
magnification view of heart). Tas2r131–expressing cells are clearly labeled in the circumvallate papillae as control. Scale bars are as indicated.
doi:10.1371/journal.pone.0064579.g003
Taste GPCRs in the Heart
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Taste GPCRs are Regulated under Conditions of
Starvation Both in vitro and in vivo
Given the purported role of Tas1 GPCRs in nutrient sensing, we
investigated the effect of nutrient deprivation on expression of taste
receptors in cultured rat cardiomyocytes. Contrary to our
expectations, Tas1r1 and Tas1r3 expression levels were unchanged
in myocytes following 24 hours glucose deprivation. Similarly,
there was no effect of amino acid deprivation on taste GPCR
expression (Figure S4). The regulation of Tas2 GPCRs has not
been thoroughly investigated with respect to nutrient status.
Intriguingly, the expression of Tas2r126, Tas2r135 and Tas2r143
increased 2–3 fold in the absence of glucose, whereas the
remaining taste GPCRs expressed were unchanged (Figure 5A,
Figure S5). These data were verified in vivo in a mouse model of
starvation, where the same Tas2rs were upregulated after 48 hours
food deprivation (Figure 5B). Taken together, these data suggest
that the cardiac expression of Tas2 receptors could have
physiological relevance as novel metabolic/nutrient sensors in
the heart.
Discussion
Using RT-qPCR, in situ hybridization, and gene-targeted
reporter mice, we demonstrate, for the first time, the expression
of individual Tas1 and Tas2 receptors in cardiomyocytes,
fibroblasts and heart tissue. In rodents, these receptors are
expressed throughout the myocardium in a small subset of cardiac
cells and some receptors are upregulated at the transcript level
in vitro and in vivo upon nutrient starvation. The cardiac-expressed
Tas2rs are located in genomic clusters and share developmental
and physiological expression patterns, suggesting common regu-
latory control. Each of these receptors described has a human
homolog, implying conservation across eutheria. Indeed, in
human heart tissue samples obtained from heart transplant
patients, taste GPCR transcripts are readily detected, most
strikingly the TAS2Rs. The delineation of Tas1/Tas2 GPCRs in
heart opens up new avenues of cardiovascular research.
Recent large-scale efforts to profile and characterize GPCR
expression in different tissues, demonstrate that the heart expresses
more than 100 GPCRs [3,4,26,27], although these studies have
pragmatically excluded the chemosensory receptors. Collectively,
these studies raise the possibility that we are overlooking important
physiological and pathophysiological GPCR targets – specifically
by focusing only on well characterized GPCRs with available,
potent and selective ligands. Recent work by Insel and colleagues
has epitomized this idea in demonstrating that a previously
unheralded, albeit ubiquitously expressed GPCR (protease acti-
vated receptor 1, PAR1), may play an important role in cardiac
fibrosis [28]. Our study is the first to systematically describe taste
GPCRs in heart and supports the idea that previous studies may
have been too narrow in their scope in profiling GPCR expression
across tissues.
Figure 4. Taste GPCRs are regulated in the heart during postnatal life in vivo. Taste GPCR mRNA expression levels at different postnatal
ages from postnatal day 1 (PN1) to 19 months. Gene expression levels are normalized to Gapdh and expressed relative to PN1 (mean6SEM, expressed
relative to PN1, n = 4, *P,0.05; **P,0.01, ***P,0.001, one-way ANOVA with a Dunnett’s post-test).
doi:10.1371/journal.pone.0064579.g004
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The type 1 (TAS1/Tas1) family taste receptors have a nutrient
sensing role in the tongue, as well as other tissues, including the
gastrointestinal tract and the brain [5,29,30]. Our specific
identification in heart of Tas1r1/Tas1r3 is consistent with a
nutrient-sensing role and may indicate a role in metabolic
regulation. Indeed, Tas1r1/Tas1r3 have very recently been
implicated as direct upstream amino acid sensors for the
mTORC1-mediated autophagy pathway [9]. While not entirely
surprising, given their well-described roles as broadly-tuned amino
acid sensors, this newly attributed function to Tas1rs outside the
mouth (and our discovery of them in heart) reinforces the notion
that these GPCRs are involved in far more than taste.
Another major finding in our study is the prevalence of the type
2 ‘‘bitter’’ (TAS2/Tas2) GPCRs in both human and rodent hearts.
We also detected the genes commonly associated with taste GPCR
signaling, endowing the heart with taste-receptor like signaling
potential, although there is no a priori reason to assume that these
are the cardiac effectors of Tas2 activation. The endogenous
complement of proteins in the heart would likely dictate the signal
transduction and hence cardiac function of these GPCRs,
although the downstream components remain to be delineated.
While Tas2rs are predominantly located within multigene clusters
in mouse, rat and human genomes, there is little known about
their tissue-specific and transcriptional regulation [31]. Neverthe-
less, the proximal chromosomal organization and clustering of the
subset of cardiac-expressed taste GPCRs, as well as their shared
regulatory patterns, suggest possible transcriptional co-regulation.
What could be the potential function for a TAS2 receptor in the
heart? The localization of taste GPCRs in discrete heart cells
parallels that seen in the respiratory and gastrointestinal systems
[13,15], suggesting that these may function as specialized cells that
sense the extracellular environment and influence surrounding
tissue. In this regard, the upregulation of a subset of the Tas2
GPCRs in the heart following nutrient deprivation and starvation
is interesting. These findings could reflect a potential function as
nutrient sensors in heart. Interestingly, taste receptors are
upregulated in several conditions where specific nutrients are
depleted [5,32], and a single nucleotide polymorphism in a human
TAS2R has been linked to deficits in glucose homeostasis [33].
Similarly, gene variants in TAS2Rs are related to disease – a
polymorphism in TAS2R38 contributes to an increased suscep-
tibility to respiratory infection [34] and a mutation in TAS2R50
has been associated with cardiovascular disease in several
population-based prospective studies [35,36], but the mechanisms
by which the variants of these TAS2 genes influence the
pathophysiology of disease are mostly unknown. Although the
present findings do not discriminate between increased TAS2
expression in a subpopulation of cells versus an increase in the
number of cells expressing the receptor, the cardiac expression of
taste GPCRs raises the possibility of a direct effect, beyond oral
sensation [37].
An obvious consideration for the cardiac expression of Tas2rs is
their ligand-mediated activation – from where do these ligands
originate and how would they get to the heart? At present, the best
candidates for activating TAS2Rs outside the gustatory system are
inhaled irritants and toxins [15,34]. It is possible that exogenous
toxins could be taken into the circulatory system to target the
cardiac-Tas2rs. An alternative possibility is that there are
endogenous TAS2R agonists produced within the circulation
and/or cardiovascular tissues. Indeed, there is a growing literature
pertaining to the metabolite ligands for GPCRs in physiology and
disease (recently reviewed in [38,39]). Notably, metabolite ligands
have been associated with a variety of receptor systems and may
have potential therapeutic applications in a variety of metabolic
diseases and in pain [40,41,42,43,44].
Clearly, the identification of TAS2Rs in the heart warrants
further investigation in cardiac physiology and disease. We are
currently working to identify potent and selective ligands for these
Tas2rs in rodents, which will appreciably aid efforts towards their
functional characterization in heart. In addition, given the
interesting species similarities/differences in TAS2Rs, it will be
important to also direct future studies to cells and tissues derived
from humans, where the characterization of TAS2R ligand
binding profiles [10] and pharmacological tools (e.g. small
molecule TAS2R antagonists [45]) are slightly more advanced.
Indeed, while chemosensory receptors represent the majority of
GPCRs in our genome, we are yet to fully understand the extent of
their biological importance in tissues beyond the nose and mouth.
Figure 5. Taste GPCRs are regulated in the heart under conditions of starvation both in vitro and in vivo. A Tas2r126, Tas2r135 and
Tas2r143 mRNA expression levels in cultured neonatal rat ventricular myocytes deprived of glucose for 24 h (mean6SEM, n= 4, fold change over
glucose-containing myocyte media conditions (DMEM)). B Tas2r126, Tas2r135 and Tas2r143mRNA expression levels in hearts of mice starved for 48 h
(mean6SEM, n = 4, fold change over fed (ad lib) controls, *P,0.05; **P,0.01, ***P,0.001, unpaired student’s t test).
doi:10.1371/journal.pone.0064579.g005
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We agree with Munger and colleagues that the extraoral
expression of TAS2Rs may be a potential confounder in the
application and understanding of GPCR-based therapeutics [46],
but reiterate that they could also be possible drug targets in their
own right.
Supporting Information
Figure S1 A Representative RT-qPCR amplification plot for rat
Tas2r143 in the presence (black traces) or absence (blue traces) of
reverse transcriptase. As shown in Table S3, four independent
samples of neonatal rat heart mRNA were assayed in triplicate. All
+RT samples amplified with Ct values approximating 27.4,
whereas 9 of 12 of the –RT replicates failed to amplify. The
remaining 3 replicates amplified at an average CT value of 34.8,
generally indistinguishable from background. B The correct
amplicon sizes of cardiac-expressed TasRs were confirmed by
running RT-qPCR samples (+ and – RT) on a 12% native PAGE
gel. Shown are three representative rat Tas2rs (Tas2r126, Tas2r135
and Tas2r143) running at their expected molecular size (139 base
pairs, 159 base pairs and 97 base pairs, respectively) relative to
marker bands at 300, 150 and 50 base pairs, as indicated.
(TIF)
Figure S2 Schematic showing the genomic organization of the
Tas2r143, 135 and 126 cluster of taste GPCRs in mouse, and the
mammalian conservation. Generated using the UCSC Genome
Browser database: http://genome.ucsc.edu/.
(TIF)
Figure S3 Taste GPCRs are expressed in the human right atria.
RT-qPCR screen of taste GPCRs in human right atria (mean 6
SEM, n=5, normalized for 18S, presented as fold change over the
angiotensin II type 1 receptor (AGTR1)). The abundantly
expressed b1-adrenergic receptor (ADRB1) is shown as a
comparator.
(TIF)
Figure S4 Amino acid deprivation (24 h) has no effect on Tas1
or Tas2 GPCR mRNA expression in cultured neonatal rat
ventricular myocytes. Data expressed as mean6SEM, n= 4, fold
change over amino acid-containing myocyte media conditions
(DMEM).
(TIF)
Figure S5 Glucose deprivation (24 h) does not modulate the
mRNA expression of a subset of taste GPCRs in cultured neonatal
rat ventricular myocytes. Data expressed as mean6SEM, n= 4,
fold change over glucose-containing myocyte media conditions
(DMEM).
(TIF)
Table S1 RT-qPCR primers and probes and their sequences/
part numbers.
(DOCX)
Table S2 In situ hybridization probe primer sequences, including
T7 and T3 RNA polymerase binding sites.
(DOCX)
Table S3 RT-qPCR experiments were performed in the
presence and absence of reverse transcriptase following DNase
treatment to confirm the specific amplification of cDNA, in
contrast to genomic DNA.
(DOCX)
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